ORAMED PHARMACEUTICALS INC. Revenue
ORAMED PHARMACEUTICALS INC. (ORMP) reported Revenue of $2.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-08-10
- ORAMED PHARMACEUTICALS INC. revenues for the quarter ending 2025-12-31 was $0.00.
- ORAMED PHARMACEUTICALS INC. revenues for the quarter ending 2025-09-30 was $0.00.
- ORAMED PHARMACEUTICALS INC. revenues for the quarter ending 2025-06-30 was $0.00.
- ORAMED PHARMACEUTICALS INC. revenues for the quarter ending 2025-03-31 was $2.00M.
- ORAMED PHARMACEUTICALS INC. revenues for fiscal 2025 was $2.00M.
- ORAMED PHARMACEUTICALS INC. revenues for fiscal 2023 was $1.34M, a 50.43% decline from fiscal 2022.
- ORAMED PHARMACEUTICALS INC. revenues for fiscal 2022 was $2.70M.
- ORAMED PHARMACEUTICALS INC. revenues for fiscal 2021 was $2.70M, a 0.26% decline from fiscal 2020.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 4 month | Revenues 6 month | Revenues 8 month | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $0.00 derived: sum of 3 quarters · filed 2026-08-10 | $2.00M 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-10 | $2.00M 10-Q · filed 2025-11-13 | |||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $2.00M 10-Q · filed 2026-08-10 | ||||||
| 2025-03-31 | $2.00M 10-Q · filed 2026-05-19 | |||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $0.00 derived: sum of 2 quarters · filed 2025-03-27 | $674.00K derived: sum of 3 quarters · filed 2025-03-27 | $1.34M 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $674.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.34M 10-Q · filed 2024-11-07 | $2.02M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | $674.00K 10-Q · filed 2024-08-14 | $1.34M 10-Q · filed 2024-08-14 | $2.02M derived: sum of 3 quarters · filed 2024-08-14 | $2.70M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $666.00K 10-Q · filed 2024-05-09 | $1.35M derived: sum of 2 quarters · filed 2024-05-09 | $2.03M derived: sum of 3 quarters · filed 2024-05-09 | $2.70M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $681.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $904.00K 10-K · filed 2023-03-06 | $1.36M derived: sum of 2 quarters · filed 2024-03-06 | $2.04M derived: sum of 3 quarters · filed 2024-03-06 | $2.70M 10-K · filed 2024-03-06 | |||
| 2022-09-30 | $682.00K 10-Q · filed 2023-11-09 | $1.36M derived: sum of 2 quarters · filed 2023-11-09 | $2.02M 10-Q · filed 2023-11-09 | |||||
| 2022-06-30 | $674.00K 10-Q · filed 2023-08-10 | $1.34M 10-Q · filed 2023-08-10 | ||||||
| 2022-03-31 | $666.00K 10-Q · filed 2023-05-11 | |||||||
| 2021-12-31 | $904.00K 10-QT · filed 2022-03-30 | |||||||
| 2021-11-30 | $674.00K 10-Q · filed 2022-01-11 | |||||||
| 2021-09-30 | $682.00K 10-Q · filed 2022-11-10 | $2.02M 10-Q · filed 2022-11-10 | ||||||
| 2021-08-31 | $683.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-24 | $2.70M 10-K · filed 2023-03-06 | $2.70M 10-K · filed 2021-11-24 | |||||
| 2021-06-30 | $674.00K 10-Q · filed 2022-08-10 | $1.34M 10-Q · filed 2022-08-10 | ||||||
| 2021-05-31 | $681.00K 10-Q · filed 2021-07-14 | $2.02M 10-Q · filed 2021-07-14 | ||||||
| 2021-03-31 | $666.00K 10-Q · filed 2022-05-12 | |||||||
| 2021-02-28 | $665.00K 10-Q · filed 2021-04-13 | $1.34M 10-Q · filed 2021-04-13 | $2.02M derived: sum of 3 quarters · filed 2022-01-11 | $2.70M derived: sum of 4 quarters · filed 2022-01-11 | ||||
| 2020-12-31 | $904.00K 10-QT · filed 2022-03-30 | |||||||
| 2020-11-30 | $674.00K 10-Q · filed 2022-01-11 | $1.35M derived: sum of 2 quarters · filed 2022-01-11 | $2.04M derived: sum of 3 quarters · filed 2022-01-11 | $2.71M derived: sum of 4 quarters · filed 2022-01-11 | ||||
| 2020-08-31 | $681.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-24 | $1.36M derived: sum of 2 quarters · filed 2021-11-24 | $2.04M derived: sum of 3 quarters · filed 2021-11-24 | $2.71M 10-K · filed 2021-11-24 | ||||
| 2020-05-31 | $681.00K 10-Q · filed 2021-07-14 | $1.35M derived: sum of 2 quarters · filed 2021-07-14 | $2.03M 10-Q · filed 2021-07-14 | $2.71M derived: sum of 4 quarters · filed 2021-07-14 | ||||
| 2020-02-29 | $674.00K 10-Q · filed 2021-04-13 | $1.35M 10-Q · filed 2021-04-13 | $2.03M derived: sum of 3 quarters · filed 2021-04-13 | $2.71M derived: sum of 4 quarters · filed 2021-04-13 | ||||
| 2019-11-30 | $674.00K 10-Q · filed 2021-01-14 | $1.35M derived: sum of 2 quarters · filed 2021-01-14 | $2.04M derived: sum of 3 quarters · filed 2021-01-14 | $2.70M derived: sum of 4 quarters · filed 2021-01-14 | ||||
| 2019-08-31 | $681.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-24 | $1.36M derived: sum of 2 quarters · filed 2020-11-24 | $2.03M derived: sum of 3 quarters · filed 2020-11-24 | $2.70M 10-K · filed 2020-11-24 | ||||
| 2019-05-31 | $682.00K 10-Q · filed 2020-07-07 | $1.35M derived: sum of 2 quarters · filed 2020-07-07 | $2.02M 10-Q · filed 2020-07-07 | $2.64M derived: sum of 4 quarters · filed 2020-07-07 | ||||
| 2019-02-28 | $666.00K 10-Q · filed 2020-04-06 | $1.34M 10-Q · filed 2020-04-06 | $1.96M derived: sum of 3 quarters · filed 2020-04-06 | $2.57M derived: sum of 4 quarters · filed 2020-04-06 | ||||
| 2018-11-30 | $674.00K 10-Q · filed 2020-01-09 | $1.29M derived: sum of 2 quarters · filed 2020-01-09 | $1.91M derived: sum of 3 quarters · filed 2020-01-09 | $2.51M derived: sum of 4 quarters · filed 2020-01-09 | ||||
| 2018-08-31 | $617.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | $1.23M derived: sum of 2 quarters · filed 2019-11-27 | $1.84M derived: sum of 3 quarters · filed 2019-11-27 | $2.45M 10-K · filed 2019-11-27 | ||||
| 2018-05-31 | $617.00K 10-Q · filed 2019-07-10 | $1.22M derived: sum of 2 quarters · filed 2019-07-10 | $1.83M 10-Q · filed 2019-07-10 | $2.45M derived: sum of 4 quarters · filed 2019-11-27 | ||||
| 2018-02-28 | $604.00K 10-Q · filed 2019-04-10 | $1.22M 10-Q · filed 2019-04-10 | $1.83M derived: sum of 3 quarters · filed 2019-11-27 | $2.45M derived: sum of 4 quarters · filed 2019-11-27 | ||||
| 2017-11-30 | $611.00K 10-Q · filed 2019-01-14 | $1.23M derived: sum of 2 quarters · filed 2019-11-27 | $1.85M derived: sum of 3 quarters · filed 2019-11-27 | $2.46M derived: sum of 4 quarters · filed 2019-11-27 | ||||
| 2017-08-31 | $618.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | $1.24M derived: sum of 2 quarters · filed 2019-11-27 | $1.85M derived: sum of 3 quarters · filed 2019-11-27 | $2.46M 10-K · filed 2019-11-27 | ||||
| 2017-05-31 | $617.00K 10-Q · filed 2018-07-12 | -$617.00K 10-Q · filed 2017-07-06 | $1.23M derived: sum of 2 quarters · filed 2018-07-12 | $1.84M 10-Q · filed 2018-07-12 | -$1.84M 10-Q · filed 2017-07-06 | $2.77M derived: sum of 4 quarters · filed 2018-11-28 | ||
| 2017-02-28 | $611.00K 10-Q · filed 2018-04-09 | $1.22M 10-Q · filed 2018-04-09 | $2.15M derived: sum of 3 quarters · filed 2018-11-28 | $1.99M derived: sum of 4 quarters · filed 2018-11-28 | ||||
| 2016-11-30 | $610.00K 10-Q · filed 2018-01-11 | -$610.00K 10-Q · filed 2017-01-11 | $1.54M derived: sum of 2 quarters · filed 2018-11-28 | $1.38M derived: sum of 3 quarters · filed 2018-11-28 | $1.50M derived: sum of 4 quarters · filed 2018-11-28 | |||
| 2016-08-31 | $929.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-28 | $766.00K derived: sum of 2 quarters · filed 2018-11-28 | $891.00K derived: sum of 3 quarters · filed 2018-11-28 | $641.00K 10-K · filed 2018-11-28 | ||||
| 2016-05-31 | -$163.00K 10-Q · filed 2017-07-06 | $163.00K 10-Q · filed 2016-07-06 | -$38.00K derived: sum of 2 quarters · filed 2017-07-06 | -$288.00K 10-Q · filed 2017-07-06 | $288.00K 10-Q · filed 2016-07-06 | |||
| 2016-02-29 | $125.00K 10-Q · filed 2016-04-06 | $125.00K 10-Q · filed 2017-04-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |